"Oral GnRH antagonists, like elagolix, are much cheaper and less invasive medication used at a lower frequency -- every other day compared to daily -- showing variable ovulation suppression to the ...

It was this study's comparison of the long GnRH agonist and the short antagonist protocols which offered its important safety finding. OHSS is a complication most usually found in patients whose ...

Gonadotropin-releasing hormone (GnRH) therapy improves cognitive function in Down syndrome (DS) mouse models and male patients with DS, according to a new study.

The risk of major adverse cardiovascular events (MACE) may differ between men taking GnRH antagonists vs LHRH agonists for prostate cancer.